The Impact of SPC on Advanced Breast Cancer Patients
2018年7月26日 更新者：Łukasz Pietrzyński、Silesian University of Medicine
The Influence of Specialist Palliative Care on the Exacerbation of Negative Symptoms, Life Quality and Performance Status of Patients With Advanced Breast Cancer
The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland.
The length of the entire study will be 36 months.
研究概览
研究类型
观察性的
注册 (实际的)
144
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
33年 至 91年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
女性
取样方法
非概率样本
研究人群
Patients with advanced stage breast cancer refered for a SPC treatment at palliative care department in Poland, Będzin.
描述
Inclusion Criteria:
the patient's conscious consent for examination and the ability to fill in the form by the patient herself.
-
Exclusion Criteria:
- patients with cognitive disturbances disabling credible answers in the questionnaire, deceased patients or those discharged from the ward before 14 days of hospitalisation.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
patients under the age of 65 years
|
In the research, Specialist Palliative Care was provided according to the guidelines established by Mid-Western Health Board in a Report of the National Advisory Committee on Palliative Care as well as according to recommendations of Polish Society of Palliative Medicine and Polish National Healthcare Fund.
In order to ensure interdisciplinary and integrated palliative care, a team of specialists was appointed.
Team members were engaged in the process of treatment of each patient during the time of the study and applied their specialist skills according to the needs of the patients
|
|
patients at the age of 65 years and over
|
In the research, Specialist Palliative Care was provided according to the guidelines established by Mid-Western Health Board in a Report of the National Advisory Committee on Palliative Care as well as according to recommendations of Polish Society of Palliative Medicine and Polish National Healthcare Fund.
In order to ensure interdisciplinary and integrated palliative care, a team of specialists was appointed.
Team members were engaged in the process of treatment of each patient during the time of the study and applied their specialist skills according to the needs of the patients
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Variation of intensification of patients negative symptoms before and after SPC
大体时间：14 days
|
intensification of patients negative symptoms was assessed by Edmonton Symptom Assessment System (esas)
|
14 days
|
|
Variation of performance status of patients before and after SPC
大体时间：14 days
|
performance status of patients was assessed by ECOG scale (Eastern Cooperative Oncology Group)
|
14 days
|
|
Variation of quality of life of patients before and after SPC
大体时间：14 days
|
quality of life of patients of patients was assessed by quality of life uniscale (QoLU)
|
14 days
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 学习椅：Jadwiga Jośko-Ochojska, prof、4. Chair and Department of Medicine and Environmental Epidemiology Medical University of Silesia in Katowice
- 首席研究员：Łukasz Pietrzyńsi、1. Medical University of Silesia, department of palliative medicine
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2015年5月1日
初级完成 (实际的)
2018年5月1日
研究完成 (实际的)
2018年5月1日
研究注册日期
首次提交
2018年7月9日
首先提交符合 QC 标准的
2018年7月26日
首次发布 (实际的)
2018年8月2日
研究记录更新
最后更新发布 (实际的)
2018年8月2日
上次提交的符合 QC 标准的更新
2018年7月26日
最后验证
2018年7月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.